Skip to main content
logo
Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
22.30
-0.04 (-0.18%)
At close: Sep 11, 2026, 4:00 PM EDT
23.11
+0.81 (3.63%)
After-hours: Sep 11, 2026, 7:30 PM EDT

Vor Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,319506138153437433
Market Cap Growth
418.13%266.35%-9.38%-65.05%0.75%-
Enterprise Value
85633910829341225
Last Close Price
22.3013.0822.2045.00133.00232.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
--3.081.431.011.742.00
P/TBV Ratio
--1.431.011.742.00

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.01-0.020.330.240.160.08
Net Debt / Equity Ratio
2.312.75-0.62-0.67-0.76-0.88
Net Debt / EBITDA Ratio
3.951.330.510.832.112.80
Net Debt / FCF Ratio
3.293.150.601.002.042.59
Quick Ratio
18.7918.094.948.8117.5520.43
Current Ratio
19.1518.205.199.0418.0621.12
Return on Equity (ROE)
---94.52%-58.74%-39.45%-52.09%
Return on Assets (ROA)
-21.37%-70.41%-44.42%-31.67%-21.55%-27.09%
Return on Capital Employed (ROCE)
-25.70%-77.90%-97.50%-69.00%-32.60%-29.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
47.58%-137.42%-84.57%-77.25%-21.09%-15.90%
FCF Yield
-10.67%-28.36%-72.25%-66.44%-21.44%-16.86%
Buyback Yield / Dilution
-540.03%-187.35%-2.26%-69.88%-18.30%-15547.86%
SEC Filings: 10-K · 10-Q